Literature DB >> 29493355

A cost-effective cell- and matrix-based minimally invasive single-stage chondroregenerative technique developed with validated vertical translation methodology.

A A Shetty1, S J Kim2, S Ahmed1, S Trattnig3, S A Kim2, H J Jang2.   

Abstract

Introduction The morbidity and significant health economic impact associated with the chondral lesion has led to a large number of strategies for therapeutic neochondrogenesis. The challenge has been to develop techniques that are cost effective single-stage procedures with minimal surgical trauma that have undergone rigorous preclinical scrutiny and robust reproducible assessment of effectiveness. A biological repair requires the generation of a cellular and matrix composite with appropriate signalling for chondrogenic differentiation. Methods and results A technique was developed that allowed chondrogenic primary (uncultured) cells from bone marrow aspirate concentrate, combined with a composite hydrophilic and fibrillar matrix to be applied arthroscopically to a site of a chondral lesion. The construct was tested in vitro and in animal experiments before clinical trials. Clinical trials involved 60 patients in a prospective study. Symptomatic International Cartilage Repair Society grade 3 and 4a lesions were mapped and treated. Pre- and postoperative clinical assessments showed statistically significant improved outcomes; Lysholm Knee Scoring Scale (mean 52.8 to > 76.4; P < 0.05) International Knee Documentation Committee (mean 39 to > 79 P < 0.05) and Knee injury and Osteoarthritis Outcome Score (64.5 to >89.2 P < 0.05). Postoperative magnetic resonance imaging was evaluated morphologically (magnetic resonance observation of cartilage repair tissue, average MOCART score 72) and qualitatively; the regenerate was comparable to native cartilage. Conclusions This technique is effective, affordable, requires no complex tools and delivers a single-stage treatment that is potentially accessible to any centre capable of performing arthroscopic surgery. Good clinical results were found to be sustained at five years of follow-up with a regenerate that appears hyaline like using multiple magnetic resonance measures.

Entities:  

Keywords:  Adenoma; Hyperplasia; Primary hyperparathyroidism

Mesh:

Year:  2018        PMID: 29493355      PMCID: PMC5930103          DOI: 10.1308/rcsann.2017.0223

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  25 in total

1.  Microfracture to treat full-thickness chondral defects: surgical technique, rehabilitation, and outcomes.

Authors:  J Richard Steadman; William G Rodkey; Karen K Briggs
Journal:  J Knee Surg       Date:  2002       Impact factor: 2.757

2.  A prospective, randomised study comparing two techniques of autologous chondrocyte implantation for osteochondral defects in the knee: Periosteum covered versus type I/III collagen covered.

Authors:  C R Gooding; W Bartlett; G Bentley; J A Skinner; R Carrington; A Flanagan
Journal:  Knee       Date:  2006-04-27       Impact factor: 2.199

Review 3.  Autologous collagen induced chondrogenesis (ACIC: Shetty-Kim technique) - A matrix based acellular single stage arthroscopic cartilage repair technique.

Authors:  Asode Ananthram Shetty; Seok Jung Kim; Vishvas Shetty; Jae Deog Jang; Sung Woo Huh; Dong Hwan Lee
Journal:  J Clin Orthop Trauma       Date:  2016-06-14

4.  Contacts with fibrils containing collagen I, but not collagens II, IX, and XI, can destabilize the cartilage phenotype of chondrocytes.

Authors:  J Farjanel; G Schürmann; P Bruckner
Journal:  Osteoarthritis Cartilage       Date:  2001       Impact factor: 6.576

5.  Effect of chondroitin sulfate and hyaluronic acid on gene expression in a three-dimensional culture of chondrocytes.

Authors:  Shohei Nishimoto; Mutsumi Takagi; Shigeyuki Wakitani; Takuya Nihira; Toshiomi Yoshida
Journal:  J Biosci Bioeng       Date:  2005-07       Impact factor: 2.894

Review 6.  Treatment selection in articular cartilage lesions of the knee: a systematic review.

Authors:  Joris E J Bekkers; Melanie Inklaar; Daniël B F Saris
Journal:  Am J Sports Med       Date:  2009-11       Impact factor: 6.202

7.  The pathobiology of focal lesion development in aging human articular cartilage and molecular matrix changes characteristic of osteoarthritis.

Authors:  Ginette R Squires; Sharon Okouneff; Mirela Ionescu; A Robin Poole
Journal:  Arthritis Rheum       Date:  2003-05

8.  Articular cartilage lesions in 993 consecutive knee arthroscopies.

Authors:  Asbjørn Arøen; Sverre Løken; Stig Heir; Elling Alvik; Arne Ekeland; Odd G Granlund; Lars Engebretsen
Journal:  Am J Sports Med       Date:  2004 Jan-Feb       Impact factor: 6.202

9.  Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation.

Authors:  M Brittberg; A Lindahl; A Nilsson; C Ohlsson; O Isaksson; L Peterson
Journal:  N Engl J Med       Date:  1994-10-06       Impact factor: 91.245

10.  Differentiating normal hyaline cartilage from post-surgical repair tissue using fast gradient echo imaging in delayed gadolinium-enhanced MRI (dGEMRIC) at 3 Tesla.

Authors:  Siegfried Trattnig; Tallal C Mamisch; Katja Pinker; Stephan Domayer; Pavol Szomolanyi; Stefan Marlovits; Florian Kutscha-Lissberg; Goetz H Welsch
Journal:  Eur Radiol       Date:  2008-02-02       Impact factor: 5.315

View more
  3 in total

Review 1.  Clinical Applicability of Adult Human Mesenchymal Stem Cell Therapy in the Treatment of Knee Osteoarthritis.

Authors:  Noor Buzaboon; Sfoug Alshammary
Journal:  Stem Cells Cloning       Date:  2020-12-17

Review 2.  Cell therapy for cartilage repair.

Authors:  Charlotte H Hulme; Jade Perry; Helen S McCarthy; Karina T Wright; Martyn Snow; Claire Mennan; Sally Roberts
Journal:  Emerg Top Life Sci       Date:  2021-10-29

Review 3.  Methodological Flaws in Meta-Analyses of Clinical Studies on the Management of Knee Osteoarthritis with Stem Cells: A Systematic Review.

Authors:  Christoph Schmitz; Christopher Alt; David A Pearce; John P Furia; Nicola Maffulli; Eckhard U Alt
Journal:  Cells       Date:  2022-03-11       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.